IP Library Granted Patent US 8,240,309
Granted Patent B2
US 8,240,309 · App. 11/941,915 · Granted Aug 14, 2012

Adjustable nasal devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,240,309
App. No.
11/941,915
Granted
Aug 14, 2012
Kind
B2
Abstract

Described herein are adjustable whole-nose nasal devices having a first passageway for communication with a first nasal passage and a second passageway for communication with a second nasal passage, an airflow resistor that inhibits expiration more than inspiration, and an adjustable connector. The adjustable connector may include one or more adjustable joints or regions that allow the whole-nose device to conform to the spacing between a subject's nostrils, and/or the orientation and angle of the subject's nostrils. Also described herein are whole-nose devices having a single airflow resistor communicating with both of a subject's nasal passages. Methods of treating a disorder using the whole-nose nasal devices are also described.

Claims (20)

1. A nasal device adapted to be secured in communication with a subject's nasal passage, comprising:

a first passageway through a first body, wherein the first passageway is configured to fluidly connect with a subject's first nasal passage;

a second passageway through a second body, wherein the second passageway is configured to fluidly connect to a subject's second nasal passage;

a passive airflow resistor configured to be secured outside of the subject's nose and connect with both the first passageway and the second passageway, wherein the airflow resistor is configured to increase the resistance to exhalation through the nasal device more than inhalation through the nasal device to create expiratory positive airway pressure;

a holdfast configured to secure the nasal device in communication with the subject's nasal passages; and

a connector connecting the first body and the second body.

2. The device of claim 1 , wherein the connector is a telescoping joint, a sliding joint, or a continuously flexible joint.

3. The device of claim 1 , wherein the connector is selected from the group consisting of: a bendable wire, a spring, an accordion tube.

4. The device of claim 1 , wherein the holdfast is part of the connector.

5. A whole-nose nasal device comprising:

a passageway configured to receive airflow from both of a subject's nasal passages so that nasal breathing, but not oral breathing, will occur through the passageway; and

a passive airflow resistor in a portion of the passageway located outside of the subject's nasal passages, wherein the airflow resistor is configured to inhibit expiration through the nasal device more than inspiration through the nasal device to create expiratory positive airway pressure.

6. The device of claim 5 , further comprising a holdfast configured to at least partly secure the device to the subject's nose so that the passageway is in communication with both of the subject's nasal passages.

7. A method of treating a disorder using a nasal device, wherein the nasal device includes a first passageway configured to communicate with a subject's right nasal passage and a second passageway configured to communicate with the subject's left nasal passage, a passive airflow resistor located outside of the subject's nasal passages, wherein the passive airflow resistor receives airflow from both the first and second passageways and inhibits expiration through the nasal device more than it inhibits inhalation through the nasal device to create expiratory positive airway pressure, and a connector, wherein the method comprises:

applying the nasal device so that the first passageway is in communication with the subject's right nasal passage and the second passageway is in communication with the subject's left nasal passage while the passive airflow resistor is outside of the subject's nasal passages; and

securing the nasal device to the subject.

8. The method of claim 7 , wherein the disorder to be treated is selected from the list consisting of: respiratory disorders, sleep disorders, gastroenterologic disorders, and cardiovascular disorders.

9. A method of treating a disorder using a whole-nose nasal device, wherein the whole-nose nasal device includes a body having a first passageway and a second passageway; and a passive airflow resistor in fluid communication with the first and second passageways, wherein the airflow resistor is configured to inhibit expiration through the nasal device more than inspiration through the nasal device to create expiratory positive airway pressure, the method comprising:

securing the first passageway of the nasal device in communication with the subject's right nasal passage and the second passageway of the nasal device in communication with the subject's left nasal passage while the passive airflow resistor is outside of the subject's nasal passages; and

inhibiting nasal expiration more than nasal inspiration.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 13, 2021
From: CERBERUS BUSINESS FINANCE, LLC
To: FOUNDATION CONSUMER HEALTHCARE, LLC (AS SUCCESSOR BY MERGER TO THERAVENT, INC.)
Reel/Frame 055301/0186 →
PATENT SECURITY AGREEMENT Recorded Feb 12, 2021
From: FOUNDATION CONSUMER HEALTHCARE, LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT
Reel/Frame 055297/0052 →
PATENT SECURITY AGREEMENT Recorded Nov 3, 2017
From: THERAVENT, INC.
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 044035/0575 →
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2017
From: NXT CAPITAL, LLC, AS AGENT
To: THERAVENT, INC.
Reel/Frame 044022/0361 →
SECURITY INTEREST Recorded Mar 30, 2017
From: THERAVENT, INC.
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041794/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS MEDICAL, INC.
To: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS) LLC
Reel/Frame 030865/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2013
From: VENTUS (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: THERAVENT, INC.
Reel/Frame 030865/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2008
From: DOSHI, RAJIV; LOOMAS, BRYAN; SATHER, ELLIOT; SERVAITES, JEFFREY W.; LEBAS, SANDRINE; MYALL, PATRICK A.; KOBELI, LEA
To: VENTUS MEDICAL, INC.
Reel/Frame 020801/0976 →